SCI时时刷

search
Comparison of American and European guidelines for cardio-oncology of heart failure
Comparison of American and European guidelines for cardio-oncology of heart failure
Heart failure is a complex clinical syndrome, whose signs and symptoms are caused by functional or structural impairment o...
The genetic basis for adult-onset idiopathic dilated cardiomyopathy in people of African descent
The genetic basis for adult-onset idiopathic dilated cardiomyopathy in people of African descent
Cardiomyopathies are a heterogeneous group of cardiac muscle disorders that result in dilated, hypertrophic, or restrictiv...
Infection as an under-recognized precipitant of acute heart failure: prognostic and therapeutic implications
Infection as an under-recognized precipitant of acute heart failure: prognostic and therapeutic implications
As the prevalence of heart failure (HF) continues to rise, prompt diagnosis and management of various medical conditions, ...
The CORolla device for energy transfer from systole to diastole: a novel treatment for heart failure with preserved ejection fraction
The CORolla device for energy transfer from systole to diastole: a novel treatment for heart failure with preserved ejection fraction
It is estimated that 30 to 50% of heart failure patients have heart failure with preserved ejection fraction (HFpEF). Mort...
Theoretical considerations for a left atrial pump in heart failure with preserved ejection fraction
Theoretical considerations for a left atrial pump in heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) is a heterogenous group of disorders, unified by findings of elevat...
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction
There is currently no widely used prognostic score in heart failure (HF) with preserved ejection fraction (HFpEF)...
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy
Cardiac fibrosis is characterized by the deposition of extracellular matrix proteins in the spaces between cardiomyocytes ...
Assessment of left atrial appendage function by echocardiography
Assessment of left atrial appendage function by echocardiography
The left atrial appendage (LAA) is considered not only to be the most frequent site of thrombus formation, but also to pla...
No transport? No worries! Cardiac telerehabilitation is a feasible and effective alternative to centre-based programs
No transport? No worries! Cardiac telerehabilitation is a feasible and effective alternative to centre-based programs
Given the under-utilisation of cardiac rehabilitation despite its benefits, there has been a shift towards alternative del...
Advances in novel devices for the treatment of heart failure
Advances in novel devices for the treatment of heart failure
Heart failure (HF) is one of the leading causes of global health impairment. Current drugs are still limited in their effe...
Conduction system pacing: promoting the physiology to prevent heart failure
Conduction system pacing: promoting the physiology to prevent heart failure
Cardiac conduction system pacing provides physiological ventricular activation by directly stimulating the conduction syst...
Illustrative review of cardiac amyloidosis by multimodality imaging
Illustrative review of cardiac amyloidosis by multimodality imaging
Cardiac involvement in amyloidosis is characterized by the extracellular deposition of misfolded proteins in the heart wit...
“Digital biomarkers” in preclinical heart failure models — a further step towards improved translational research
“Digital biomarkers” in preclinical heart failure models — a further step towards improved translational research
Innovations in the development of novel heart failure therapies are essential to further increase the predictive value of ...
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin
Heart failure with preserved ejection fraction (HFpEF) is a highly prevalent syndrome with multifaceted pathophysiology. A...
Efficacy of peritoneal dialysis in patients with refractory congestive heart failure: a systematic review and meta-analysis
Efficacy of peritoneal dialysis in patients with refractory congestive heart failure: a systematic review and meta-analysis
Refractory congestive heart failure (RCHF) is a common complication in the natural history of advanced heart failure. Peri...
Changes of energy metabolism in failing heart and its regulation by SIRT3
Changes of energy metabolism in failing heart and its regulation by SIRT3
Heart failure (HF) is the leading cause of hospitalization in elderly patients and a disease with extremely high morbidity...
Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of literature and meta-analysis
Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of literature and meta-analysis
Close and frequent follow-up of heart failure (HF) patients improves clinical outcomes. Mobile telemonitoring applications...
Cognitive impairment in patients with heart failure: molecular mechanism and therapy
Cognitive impairment in patients with heart failure: molecular mechanism and therapy
Heart failure (HF) is associated with multiple organ dysfunction and many comorbidities. Its incidence is high among the e...
Risk of incident heart failure after COVID-19 recovery: a systematic review and meta-analysis
Risk of incident heart failure after COVID-19 recovery: a systematic review and meta-analysis
Patients recovered from COVID-19 have an increased incidence of cardiovascular disease and heart structural changes. The a...
Neuropsychiatric disorders in patients with heart failure: not to be ignored
Neuropsychiatric disorders in patients with heart failure: not to be ignored
Among various neuropsychiatric disorders, depression and anxiety are commonly encountered in patients with heart failure (...
Experimental heart failure models in small animals
Experimental heart failure models in small animals
Heart failure (HF) is one of the most critical health and economic burdens worldwide, and its prevalence is continuously i...
Left ventricular assist device in cardiac amyloidosis: friend or foe?
Left ventricular assist device in cardiac amyloidosis: friend or foe?
The prevalence of cardiac amyloidosis has progressively increased over the last years, being recognized as a significant c...
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?
In the past five decades, the use of the magnetic resonance (MR) technique for cardiovascular diseases has engendered much...
Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction
Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) accounts for more than half of heart failure hospital admissions in...
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction
For decades, cardiologists have largely underestimated the role of the right heart in heart failure due to left heart dise...